Oxymizer® pendant nasal cannula
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Klaus Kenn
Overview
Oxymizer® pendant nasal cannula is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Oxymizer® pendant nasal cannula clinical trials
Explore related
Medical disclaimer. This page summarizes research about Oxymizer® pendant nasal cannula for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.